Cyclacel Pharmaceuticals Inc. 6% Convertible Preferred Stock

(CYCCP) Trade

By |

Profile

Cyclacel Pharmaceuticals Inc mainly develops targeted medicines for cancer and other proliferative diseases. The company focuses in hematology and oncology-based development pipeline of novel drug candidates.

Contact Information

Website: www.cyclacel.com
Email: ir@cyclacel.com
Main Phone: +1 908 517-7330
Address: 200 Connell Drive
Address 2: Suite 1500
State: NJ
City / Town: Berkeley Heights
Country: USA
Postal Code: 07922

Issuer Information

Exchange: NSC
CEO: Spiro Rombotis
Employees: 12
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 5.60 $ 0. (0.00%)
Last Price 5.60 Change $ 0. Change % 0.00 Tick N/A
Bid 4.90 Bid Size 900.00 Ask 7.00 Ask Size 200.00
Open N/A High N/A Low N/A Prev Close 5.60
Last Trade Volume 0 52 Wk Hi 7.75 52 Wk Low 4.94
Market Cap 1.9 mi Ex-Div Date Div Rate 0.60 Yield 10.7140
Shares 335,273.00 EPS (TTM) N/A PE Ratio N/A Exchange NCM